Literature DB >> 19766767

Direct measurement of vena contracta area by real-time 3-dimensional echocardiography for assessing severity of mitral regurgitation.

Chaim Yosefy1, Judy Hung, Sarah Chua, Mordehay Vaturi, Thanh-Thao Ton-Nu, Mark D Handschumacher, Robert A Levine.   

Abstract

We tested the hypothesis that the vena contracta (VC) cross-sectional area in patients with mitral regurgitation (MR) can be reproducibly measured by real-time 3-dimensional (3D) echocardiography and correlates well with the volumetric effective regurgitant orifice area (EROA). Earlier MR repair requires accurate noninvasive measures, but practically, the VC area is difficult to image in 2-dimensional views, which are often oblique to it. 3D echocardiography can provide an otherwise unobtainable true cross-sectional view. In 45 patients with mild or greater MR, 44% eccentric, 2-dimensional and 3D VC areas were measured and correlated with the EROA derived from the regurgitant stroke volume. Real-time 3D echocardiography of the VC area correlated and agreed well with the EROA for both central and eccentric jets (r(2) = 0.86, SEE 0.02 cm(2), difference 0.04 +/- 0.06 cm(2), p = NS). For eccentric jets, 2-dimensional echocardiography overestimated the VC width compared with 3D echocardiography (p = 0.024) and correlated more poorly with the EROA (r(2) = 0.61 vs 0.85, p <0.001), causing clinical misclassification in 45% of patients with eccentric MR. The interobserver variability for the 3D VC area was 0.03 cm(2) (7.5% of the mean, r = 0.95); the intraobserver variability was 0.01 cm(2) (2.5% of the mean, r = 0.97). In conclusion, real-time 3D echocardiography accurately and reproducibly quantified the vena contracta cross-sectional area in patients with both central and eccentric MR. Rapid acquisition and intuitive analysis promote practical clinical application of this central, directly visualized, measure and its correlation with outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19766767      PMCID: PMC2767113          DOI: 10.1016/j.amjcard.2009.05.043

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Quantitative assessment of severity of ventricular septal defect by three-dimensional reconstruction of color Doppler-imaged vena contracta and flow convergence region.

Authors:  M Ishii; K Hashino; G Eto; T Tsutsumi; W Himeno; Y Sugahara; H Muta; J Furui; T Akagi; Y Ito; H Kato
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

2.  Three-dimensional reconstruction of the color Doppler-imaged vena contracta for quantifying aortic regurgitation: studies in a chronic animal model.

Authors:  Y Mori; T Shiota; M Jones; S Wanitkun; T Irvine; X Li; A Delabays; N G Pandian; D J Sahn
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

3.  The power-velocity integral at the vena contracta: A new method for direct quantification of regurgitant volume flow.

Authors:  T Buck; R A Mucci; J L Guerrero; G Holmvang; M D Handschumacher; R A Levine
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

4.  Broad-beam spectral Doppler sonification of the vena contracta using matrix-array technology: A new solution for semi-automated quantification of mitral regurgitant flow volume and orifice area.

Authors:  Thomas Buck; Björn Plicht; Peter Hunold; Ronald A Mucci; Raimund Erbel; Robert A Levine
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

Review 5.  Role of real time 3D echocardiography in evaluating the left ventricle.

Authors:  Mark J Monaghan
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

6.  Real-time 3-dimensional color Doppler flow of mitral and tricuspid regurgitation: feasibility and initial quantitative comparison with 2-dimensional methods.

Authors:  Lissa Sugeng; Lynn Weinert; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2007-06-20       Impact factor: 5.251

7.  Temporal variability of vena contracta and jet areas with color Doppler in aortic regurgitation: a chronic animal model study.

Authors:  M Ishii; M Jones; T Shiota; I Yamada; B Sinclair; R S Heinrich; A P Yoganathan; D J Sahn
Journal:  J Am Soc Echocardiogr       Date:  1998-11       Impact factor: 5.251

8.  Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment.

Authors:  F Grigioni; M Enriquez-Sarano; K J Zehr; K R Bailey; A J Tajik
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

9.  Quantitative determinants of the outcome of asymptomatic mitral regurgitation.

Authors:  Maurice Enriquez-Sarano; Jean-François Avierinos; David Messika-Zeitoun; Delphine Detaint; Maryann Capps; Vuyisile Nkomo; Christopher Scott; Hartzell V Schaff; A Jamil Tajik
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

10.  Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience.

Authors:  Stephen H Little; Bahar Pirat; Rahul Kumar; Stephen R Igo; Marti McCulloch; Craig J Hartley; Jiaqiong Xu; William A Zoghbi
Journal:  JACC Cardiovasc Imaging       Date:  2008-11-18
View more
  13 in total

Review 1.  Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system.

Authors:  P Boekstegers; J Hausleiter; S Baldus; R S von Bardeleben; H Beucher; C Butter; O Franzen; R Hoffmann; H Ince; K H Kuck; V Rudolph; U Schäfer; W Schillinger; N Wunderlich
Journal:  Clin Res Cardiol       Date:  2014-02       Impact factor: 5.460

2.  Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial).

Authors:  Paul A Grayburn; Lilin She; Brad J Roberts; Krzysztof S Golba; Krzysztof Mokrzycki; Jaroslaw Drozdz; Alexander Cherniavsky; Roman Przybylski; Krzysztof Wrobel; Federico M Asch; Thomas A Holly; Haissam Haddad; Michael Yii; Gerald Maurer; Irving Kron; Hartzell Schaff; Eric J Velazquez; Jae K Oh
Journal:  Am J Cardiol       Date:  2015-06-25       Impact factor: 2.778

3.  Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography.

Authors:  Xin Zeng; Robert A Levine; Lanqi Hua; Eleanor L Morris; Yuejian Kang; Mary Flaherty; Nina V Morgan; Judy Hung
Journal:  Circ Cardiovasc Imaging       Date:  2011-07-05       Impact factor: 7.792

Review 4.  [Real-time 3D echocardiography for estimation of severity in valvular heart disease : Impact on current guidelines].

Authors:  T Buck; L Bösche; B Plicht
Journal:  Herz       Date:  2017-05       Impact factor: 1.443

Review 5.  Advanced imaging in valvular heart disease.

Authors:  Jeroen J Bax; Victoria Delgado
Journal:  Nat Rev Cardiol       Date:  2017-01-27       Impact factor: 32.419

6.  Assessment of mitral valve disease: a review of imaging modalities.

Authors:  Shweta R Motiwala; Francesca N Delling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-07

7.  Quantification of mitral valve regurgitation with color flow Doppler using baseline shift.

Authors:  Hannah Heß; Sarah Eibel; Chirojit Mukherjee; Udo X Kaisers; Joerg Ender
Journal:  Int J Cardiovasc Imaging       Date:  2012-06-30       Impact factor: 2.357

8.  Comparison between 2D and 3D echocardiography for quantitative assessment of mitral regurgitation: Current status.

Authors:  Sudhakar Subramani
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

Review 9.  Role of modern 3D echocardiography in valvular heart disease.

Authors:  Takahiro Shiota
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

Review 10.  Real-Time Three-Dimensional Echocardiographic Assessment of Severity of Mitral Regurgitation Using Proximal Isovelocity Surface Area and Vena Contracta Area Method. Lessons We Learned and Clinical Implications.

Authors:  Thomas Buck; Björn Plicht
Journal:  Curr Cardiovasc Imaging Rep       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.